About this trial
Lymphedema is a chronic condition causing fluid buildup in affected limbs. Traditional treatments often fall short, but subcutaneous implantation of hydrophobic silicone tubes shows promise, creating artificial drainage pathways. This approach proved effective in managing obstructive lymphedema in lower limbs. Further research is needed to validate its efficacy and explore long-term outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Lower limb lymphedema (Grade II-IV)
Total occlusion at lymphoscintigraphy
Patients treated at Centro Hospitalar Universitário de São João by the same surgical team
Age >18 years old;
Disqualifiers
Secondary lymphedema
Congenital lymphedema (Milroy, Meige, Klinefelter, Noonan, and Turner syndromes)
Acute infection of the limb
Chronic venous insufficiency
Trial design
Parallel
Treatments tested in this trial
implantation of hydrophobic tubes for edema fluid drainage
Procedure/Surgery1 - A 2-cm-long incision is made at the border of the hypogastrium or lumbar region 10 cm above the inguinal crease; 2- A 1.5-cm-wide and 100-cm-long metal tube tunneling device is introduced under the skin and bluntly passed in the subcutaneous tissue toward the thigh and internal aspect of the calf; 3- Incisions 2 cm long are made in the groin and calf, through which the tunneling device was passed; 4-The hydrophobic tube is passed upward through the tunneling device, after which the tunneling device is removed; 5-The upper and lower ends of the hydrophobic tubes are fixed to the fascia with absorbable sutures.
Best Medical Treatment
DeviceCompressive therapy, Phisioterapy, venous intervention
Treatment groups
Trial outcomes
Primary outcomes
Lower limb circumference in cm
Lower limb circumference in cm - ankle, calf 15 cm below the knee; knee; thigh 15 cm above the knee
Secondary outcomes
PROMS - Lymphedema quality of life
diseae specific qol questionnaire
PROMS - SF 36
Qol questionnaire
Lymphoscintigraphy
diagnostic exam
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: